This HTML5 document contains 81 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n17https://global.dbpedia.org/id/
schemahttp://schema.org/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n6http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
n12http://www.grid.ac/institutes/
n13http://commons.wikimedia.org/wiki/Special:FilePath/
n19http://arbutusbio.com/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbchttp://dbpedia.org/resource/Category:
dbphttp://dbpedia.org/property/
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Arbutus_Biopharma
rdf:type
n6:Agent dbo:Agent dbo:Organisation owl:Thing wikidata:Q24229398 dbo:Company schema:Organization wikidata:Q4830453 wikidata:Q43229 n6:SocialPerson
rdfs:label
Arbutus Biopharma
rdfs:comment
Arbutus Biopharma Corporation is a publicly traded Canadian (NASDAQ: ABUS) biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Vancouver, British Columbia and has research facilities in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.
foaf:name
Arbutus Biopharma Corporation
foaf:homepage
n19:
dbp:name
Arbutus Biopharma Corporation
foaf:depiction
n13:Arbutus_Biopharma_logo.png
dcterms:subject
dbc:Biopharmaceutical_companies dbc:Pharmaceutical_companies_of_Canada dbc:2007_establishments_in_British_Columbia dbc:Pharmaceutical_companies_established_in_2007
dbo:wikiPageID
43622827
dbo:wikiPageRevisionID
1095739101
dbo:wikiPageWikiLink
dbr:Biotechnology dbr:British_Columbia dbr:Alexion_Pharmaceuticals dbr:United_States_Department_of_Defense dbr:TKM-Ebola dbr:NASDAQ dbr:Vincristine dbr:OMERS dbc:Biopharmaceutical_companies dbr:Russell_2000_Index dbr:Patisiran dbc:Pharmaceutical_companies_of_Canada dbr:Alnylam_Pharmaceuticals dbr:Lynx_Therapeutics dbr:Topotecan dbr:Vancouver dbr:MRNA dbr:Liposome dbr:RNA_interference dbr:Warminster,_Pennsylvania dbr:Spectrum_Pharmaceuticals dbr:Hepatitis_B dbc:2007_establishments_in_British_Columbia dbr:Vinorelbine dbc:Pharmaceutical_companies_established_in_2007 dbr:West_African_Ebola_virus_epidemic dbr:Biopharmaceutical dbr:RNAi dbr:Pennsylvania dbr:Ebola_fever
dbo:wikiPageExternalLink
n19:
owl:sameAs
n17:j5pj wikidata:Q17747021 yago-res:Arbutus_Biopharma
dbp:wikiPageUsesTemplate
dbt:Short_description dbt:Start_date_and_age dbt:Authority_control dbt:Official_website dbt:Rp dbt:Reflist dbt:Infobox_company
dbo:thumbnail
n13:Arbutus_Biopharma_logo.png?width=300
dbp:hqLocationCity
dbr:Vancouver
dbp:industry
dbr:Biotechnology
dbp:logo
File:Arbutus Biopharma logo.png
dbp:products
HBV Therapies, AB-729, AB-836
dbp:tradedAs
NASDAQ:ABUS dbr:Russell_2000_Index
dbp:type
Public
dbp:website
n19:
dbo:abstract
Arbutus Biopharma Corporation is a publicly traded Canadian (NASDAQ: ABUS) biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Vancouver, British Columbia and has research facilities in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007.
skos:closeMatch
n12:grid.476087.a n12:grid.418053.b
prov:wasDerivedFrom
wikipedia-en:Arbutus_Biopharma?oldid=1095739101&ns=0
dbo:wikiPageLength
11526
dbo:foundingYear
2007-01-01
dbo:industry
dbr:Biotechnology
dbo:locationCity
dbr:Vancouver
foaf:isPrimaryTopicOf
wikipedia-en:Arbutus_Biopharma